IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 166 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $282,000 | +8.0% | 22,425 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $261,000 | -10.9% | 22,425 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $293,000 | +1.4% | 22,425 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $289,000 | +15.1% | 22,425 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $251,000 | -1.6% | 22,425 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $255,000 | +26.2% | 22,425 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $202,000 | -12.6% | 22,425 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $231,000 | +2.2% | 22,425 | 0.0% | 0.01% | -14.3% |
| Q1 2020 | $226,000 | -25.7% | 22,425 | -1.8% | 0.01% | -12.5% |
| Q4 2019 | $304,000 | +57.5% | 22,845 | +1.9% | 0.01% | +33.3% |
| Q3 2019 | $193,000 | -21.2% | 22,425 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $245,000 | -19.1% | 22,425 | 0.0% | 0.01% | -30.0% |
| Q1 2019 | $303,000 | +30.6% | 22,425 | 0.0% | 0.01% | +11.1% |
| Q4 2018 | $232,000 | -44.0% | 22,425 | 0.0% | 0.01% | -30.8% |
| Q3 2018 | $414,000 | -3.5% | 22,425 | 0.0% | 0.01% | -13.3% |
| Q2 2018 | $429,000 | +24.0% | 22,425 | 0.0% | 0.02% | +15.4% |
| Q1 2018 | $346,000 | +3.0% | 22,425 | 0.0% | 0.01% | +8.3% |
| Q4 2017 | $336,000 | -5.1% | 22,425 | 0.0% | 0.01% | -14.3% |
| Q3 2017 | $354,000 | -16.3% | 22,425 | 0.0% | 0.01% | -12.5% |
| Q2 2017 | $423,000 | +10.4% | 22,425 | 0.0% | 0.02% | +6.7% |
| Q1 2017 | $383,000 | +11.7% | 22,425 | 0.0% | 0.02% | +7.1% |
| Q4 2016 | $343,000 | -3.7% | 22,425 | 0.0% | 0.01% | -6.7% |
| Q3 2016 | $356,000 | +21.5% | 22,425 | 0.0% | 0.02% | +15.4% |
| Q2 2016 | $293,000 | +19.6% | 22,425 | 0.0% | 0.01% | +18.2% |
| Q1 2016 | $245,000 | -5.8% | 22,425 | 0.0% | 0.01% | -8.3% |
| Q4 2015 | $260,000 | +11.1% | 22,425 | 0.0% | 0.01% | +9.1% |
| Q3 2015 | $234,000 | -13.7% | 22,425 | 0.0% | 0.01% | -8.3% |
| Q2 2015 | $271,000 | -24.5% | 22,425 | 0.0% | 0.01% | -25.0% |
| Q1 2015 | $359,000 | +248.5% | 22,425 | +231.7% | 0.02% | +220.0% |
| Q4 2014 | $103,000 | +17.0% | 6,760 | 0.0% | 0.01% | +25.0% |
| Q3 2014 | $88,000 | -14.6% | 6,760 | 0.0% | 0.00% | -20.0% |
| Q2 2014 | $103,000 | +24.1% | 6,760 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $83,000 | +1283.3% | 6,760 | +1252.0% | 0.01% | – |
| Q4 2013 | $6,000 | -93.8% | 500 | -93.9% | 0.00% | -100.0% |
| Q3 2013 | $97,000 | +90.2% | 8,148 | +59.0% | 0.01% | +100.0% |
| Q2 2013 | $51,000 | – | 5,123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |